82 related articles for article (PubMed ID: 25968484)
1. Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results.
Kumar P; Singh B; Ghai A; Hazari PP; Mittal BR; Mishra AK
J Labelled Comp Radiopharm; 2015 May; 58(6):242-9. PubMed ID: 25968484
[TBL] [Abstract][Full Text] [Related]
2. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection.
Kaul A; Hazari PP; Rawat H; Singh B; Kalawat TC; Sharma S; Babbar AK; Mishra AK
Int J Infect Dis; 2013 Apr; 17(4):e263-70. PubMed ID: 23218675
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
Fernandes RS; Silva Jde O; Lopes SC; Chondrogiannis S; Rubello D; Cardoso VN; Oliveira MC; Ferreira LA; de Barros AL
Nucl Med Commun; 2016 Mar; 37(3):307-12. PubMed ID: 26619397
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
[TBL] [Abstract][Full Text] [Related]
6. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
Korde A; Mallia M; Shinto A; Sarma HD; Samuel G; Banerjee S
Cancer Biother Radiopharm; 2014 Nov; 29(9):387-94. PubMed ID: 25379612
[TBL] [Abstract][Full Text] [Related]
7. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
Lerthirunwong C; Cheng KT; Hladik WB
Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of [99m]Tc-labeled doxorubicin as a potential scintigraphic probe for tumor imaging.
Kumar P; Singh B; Sharma S; Ghai A; Chuttani K; Mishra AK; Dhawan D; Mittal BR
Cancer Biother Radiopharm; 2012 Apr; 27(3):221-5. PubMed ID: 22432523
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Sohaib M; Afshan A; Saeed S; Khalid MA; Yousuf M
Pak J Pharm Sci; 2014 Sep; 27(5):1287-94. PubMed ID: 25176364
[TBL] [Abstract][Full Text] [Related]
10. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
12. Kit formulation for the preparation of radioactive blue liposomes for sentinel node lymphoscintigraphy.
Plut EM; Hinkle GH; Guo W; Lee RJ
J Pharm Sci; 2002 Jul; 91(7):1717-32. PubMed ID: 12115835
[TBL] [Abstract][Full Text] [Related]
13. A simplified kit for instant preparation of technetium-99m human immunoglobulin-G for imaging inflammatory foci.
Singh AK; Mishra P; Kashyap R; Chauhan UP
Nucl Med Biol; 1994 Feb; 21(2):277-81. PubMed ID: 9234294
[TBL] [Abstract][Full Text] [Related]
14. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
Zhang K; An R; Gao Z; Zhang Y; Aruva MR
Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
[TBL] [Abstract][Full Text] [Related]
15. A Walker 256 tumor-induced osteogenic small animal model for the evaluation of [99mTc] diphosphonate radiopharmaceuticals.
Cheng KT; Shaw SM; Pinkerton TC; Hoch DJ; Van Sickle DC
Int J Nucl Med Biol; 1985; 12(3):197-208. PubMed ID: 4066198
[TBL] [Abstract][Full Text] [Related]
16. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Pharmacol Exp Ther; 2004 Feb; 308(2):419-25. PubMed ID: 14610219
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
[TBL] [Abstract][Full Text] [Related]
18. Studies on batch formulation of a kit for the preparation of the 99mTc-Ubiquicidin (29-41): An infection imaging agent.
Arjun C; Mukherjee A; Bhatt J; Chaudhari P; Repaka KM; Venkatesh M; Samuel G
Appl Radiat Isot; 2016 Jan; 107():8-12. PubMed ID: 26405838
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of (99m)Tc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors.
Kumar P; Singh B; Ghai A; Chuttani K; Dhawan D; Mittal BR; Mishra AK
Appl Radiat Isot; 2015 May; 99():41-5. PubMed ID: 25702887
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of (99m)Tc-DMSA lyophilized kit for renal imaging.
Jan SU; Abbass HG
Pak J Pharm Sci; 2013 May; 26(3):547-51. PubMed ID: 23625428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
